Skip to main content

Table 3 Angulation of mesotropic genes in reference to the horizontal for the linear normal esebssiwaagoTQ effective intracellular pressure unit

From: Anglemetry of neural axis cell differentiation genes by structural pressurotopy of DNA loop strand segment tropy in reference to tissue macro-compliance

Gene (no. of locus bases; no. of gene bases or n/a)

Gene locus (ch, strand)

Episode category (final SEB structure)

sebs f(x)a

sebssiwa f(x)a

bsebs/bsebssiwab

sebs – sebssiwa (x1, y1; x2, y2), residual

uppesebssiwaa, dppesebssiwaa

(Peff esebssiwaagoTQ)

Angulation (0)

CYGB, cytoglobin

(30,336; 30,250)

17q25.1

(−)

2 A 4

6.0565E+ 04 e2E-06x

3.0282E+ 04 e5E-06x

2.00

17,590, 111,250; 23,302, 53,661

20,446, 82,455

(0.248)

60

RGS1, regulator of g protein signaling 1 (4,305; n/a)

1q31.2

(+)

3 M 4

9.03665E+ 05 e1E-06x

4.51832E+ 05

e3E-06x

2.00

89,587, 616,793; 184,166, 343,212

136,876, 481,002

(0.285)

55.6

ENPP1, ectonucleotide pyrophosphatase phosphodiesterase 1

(87,140; n/a)

6q23.2 (+)

2 A 5

1.94930E+05 e5E-06x

5.1723E+04

e1E-05x

3.77

18,018, 114,138; 30,875, 72,458

19,942,64,814

(0.308c)

52.8

SOX18,

SRY-Box 18

(2,060; n/a)

20q13.33

(−)

3 M 3 q term

̶

̶

n/a

nil, nil;

30,318, 61,868

21,741, 70,370

(0.309)

52.7

NUMA1, nuclear mitotic apparatus protein 1

(5,063; n/a)

11q13.3-q13.4

(−)

2 A 5

3.67204E+05 e1E-05x

9.0203E + 04

e4E-06x

4.07

21,080, 172,300; 39,809, 75,825

25,175, 80,987

(0.311)

52.4

INSL3, insulin like 3

(5,063; n/a)

19p13.11

(−)

3 A 7

4.59932E+05 e7E-06x

9.0816E+04

e8E-06x

5.06

32,763, 248,680; 74,198, 133,207

74,198, 133,207

(0.321)

51.2

NFE2L2, Nuclear Factor Erythroid 2-Related Factor 2

(880,745; n/a)

2q31.2

(−)

6 A 11

5.23516E+05 e2E-06x

8.7324E+04

e1E-05x

5.995

49,163, 482,332;

448,729, 1,087,741

61,007, 184,201

(0.331)

50.2

JUND, JunD proto-oncogene, AP-1 transcription factor subunit

(1,963; n/a)

19p13.11

(−)

3 M 7

1.18726E+05 e7E-06x

3.9484E+04 e2E-05x

3.01

14,691, 92,423; 126,964, 294,152

24,833, 72,144

(0.344)

48.4

PRDM1, PR/SET domain 1

(23,620; n/a)

6q21

(+)

2 A 5

1.55684E+05 e2E-06x

4.5086E+04 e2E-05x

3.45

22,702, 109,291; 39,270, 87,689

25,311,71,167 (0.356c)

47

RGS13, regulator of g protein signaling 1

(24,174; n/a)

1q31.2

(+)

2 M 5

2.77812E+05 e3E-06x

1.39157E+05 e5E-06x

1.996

9,939, 146,229; 294,492, 580,065

78,592 218,130 (0.360)

46.5

CEACAM1, carcinoembryonic antigen-related cell adhesion molecule 1

(54,447; 53,931)

19q13.2 (−)

2 M 5

1.13842E+05 e7E-06x

5.6780E+04

e1E-05x

2.005

13,221, 67,686; 126,663, 263,463

38,276, 99,708

(0.384)

43.6

GABPA, GA binding protein transcription factor subunit alpha

(37,891; n/a)

21q21.3

(+)

2 M 3

̶

̶

n/a

nil, nil;

231,930,

438,396

120,417, 243,978

(0.494)

30.3

CD34, CD34 molecule

(34,319; 30,431)

1q32.2

(−)

2 M 3

̶

̶

n/a

nil, nil;

97,262, 145,422

48,882, 75,493

(0.648c)

11.7

  1. af(x) = b·em·x, where b is the downstream anisotropic effect (intercept and slope are absolute values); bbsebs/bsebssiwa is the linearization quotient; and cpreviously reported episode and sub-episode block structure and esebssiwaagoTQ value as per references, ENPP1, PRDM1 and CD34 [26, 27]. Note: 1) Gene loci sub-episode block structure (SEB) variations include non-contributory anisotropy (NCA), anisotropy converted to mesotropy (ACM), and/or 0.5-factor adjusted stabilizing mesotropy or anisotropy converted to stabilizing isotropy for anisotropy or mesotropy (stIAfM, stIMfA or stIMfM) that result in an initial to final SEB conversion; 2) previously reported episode and sub-episode block structure is applied in all cases as per reference [25], in which gene/gene loci at cusps of the delineated base intervals, in which case NFE2L2 (880.745) classifies into the adjacent interval; 3) Sub-episode block structures for initial to final SEB converted genes are CYGB, 2 A 5 (−1) ACM; RGS1, 3 M 7 (−3) stIMfA stIMfA; SOX18, 3 M 7 (−4) q terminal end; NFE2L2, 6 A 13 (−2) ACM; GABPA, 2 M 5 (− 2) ACM; and CD34, 2 M 5(− 2) NCA; and 3) the bsebs/bsebssiwa for CYGB and RGS1 is by reverse x-intercept plotting of the uppasebs, uppamsebs, dppasebs and dppmsebs and the corelate uppasebssiwa, uppamsebssiwa, dppasebssiwa and dppmsebssiwa
Back to article page

Translational Medicine Communications

ISSN: 2396-832X

Contact us